tetradecanoylphorbol acetate has been researched along with kamebakaurin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, BY; Koo, TH; Lee, JH; Lee, JJ | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and kamebakaurin
| Article | Year |
|---|---|
Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes.
Topics: Diterpenes; DNA; Humans; Jurkat Cells; Lipopolysaccharides; NF-kappa B; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2002 |